Neochem Bio Solutions (NSE:NEOCHEM) Short-Term Debt: ₹171 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEOCHEM Neochem Bio Solutions Ltd NSE:NEOCHEM
21 GF Score
Price ₹105.00
! 3 Warning Signs
View Full Analysis

What is Neochem Bio Solutions Short-Term Debt?

Neochem Bio Solutions NSE:NEOCHEM +2.42% 21 Short-Term Debt is ₹171 Mil as of Mar. 2026. GuruFocus rates NSE:NEOCHEM with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Neochem Bio Solutions's Short-Term Debt for the quarter that ended in Mar. 2026 was ₹171 Mil.

Neochem Bio Solutions's quarterly Short-Term Debt increased from Mar. 2025 (₹213 Mil) to Sep. 2025 (₹252 Mil) but then declined from Sep. 2025 (₹252 Mil) to Mar. 2026 (₹171 Mil).

Neochem Bio Solutions's annual Short-Term Debt increased from Mar. 2024 (₹152 Mil) to Mar. 2025 (₹213 Mil) but then declined from Mar. 2025 (₹213 Mil) to Mar. 2026 (₹171 Mil).

Neochem Bio Solutions Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Neochem Bio Solutions Short-Term Debt Related Terms

Neochem Bio Solutions Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Neochem Bio Solutions's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neochem Bio Solutions Short-Term Debt Chart

Neochem Bio Solutions Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Short-Term Debt
138.31 152.05 213.45 170.96

Neochem Bio Solutions Quarterly Data
Mar23 Mar24 Mar25 Sep25 Mar26
Short-Term Debt 138.31 152.05 213.45 251.72 170.96
NSE:NEOCHEM
21GF Score
Neochem Bio Solutions Ltd NSE:NEOCHEM
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹171 Mil mean?
Neochem Bio Solutions (NSE:NEOCHEM) has a Short-Term Debt of ₹171 Mil as of Mar. 2026.
Is Neochem Bio Solutions' Short-Term Debt too high?
Neochem Bio Solutions' current Short-Term Debt is ₹171 Mil. Overall, Neochem Bio Solutions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Neochem Bio Solutions' Short-Term Debt compare to LIN and SHW?
Neochem Bio Solutions' Short-Term Debt of ₹171 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Chemicals company?
A good Short-Term Debt depends on the Chemicals industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Neochem Bio Solutions's current Short-Term Debt is ₹171 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neochem Bio Solutions stock overvalued right now?
Neochem Bio Solutions (NSE:NEOCHEM) has a current Short-Term Debt of ₹171 Mil. The current Short-Term Debt is ₹171 Mil. Neochem Bio Solutions' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Neochem Bio Solutions (NSE:NEOCHEM), the current Short-Term Debt is ₹171 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neochem Bio Solutions Business Description

Address Iscon Ambli Road, 303, W1, Opposite Vikramnagar Colony office, Daskroi, Ahmedabad, GJ, IND, 380058
Neochem Bio Solutions Ltd is a specialty performance chemical company. Its primary product segments such as Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
21GF Score

Get the complete analysis for NSE:NEOCHEM

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹105.00
Price